Establishing meaningful change thresholds for European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire CLL‐specific module domain scores: An analysis based on the TRANSCEND CLL 004 study in patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma

Documenti analoghi

• A decade of chronic lymphocytic leukaemia therapy in Germany: Real‐world treatment patterns and outcomes (2010–2022)
  di: Hannes Wartmann, et al.
  Pubblicazione: (2024)
• Uptake of the first to fifth doses of coronavirus disease 2019 vaccine in individuals with chronic lymphocytic leukaemia: A nationwide cohort study in Sweden
  di: Pontus Hedberg, et al.
  Pubblicazione: (2025)
• Noninvasive prenatal testing in CLL during pregnancy: A cautionary tale
  di: Jorn L. J. C. Assmann, et al.
  Pubblicazione: (2025)
• Intracytoplasmic inclusions in chronic lymphocytic leukemia cells of an elderly person living with human immunodeficiency virus and presenting with Richter transformation to Hodgkin lymphoma
  di: Evashin Pillay, et al.
  Pubblicazione: (2025)
• MicroRNAs: Potential prognostic and theranostic biomarkers in chronic lymphocytic leukemia
  di: Afgar Ali, et al.
  Pubblicazione: (2024)